Skip to Content

Livewire Ergogenics Inc LVVV

Morningstar Rating
$0.00 0.00 (5.88%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

LVVV is trading at a 43% discount.
Price
$0.00
Fair Value
$7.32
Uncertainty
Extreme
1-Star Price
$5.93
5-Star Price
$8.18
Economic Moat
Pggw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if LVVV is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.01
Bid/Ask
$0.00 / $0.00
Market Cap
$1.91 Mil
Volume/Avg
874,709 / 924,316

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Livewire Ergogenics Inc is operating in the cannabis-related health and wellness industry. It focused on acquiring special-purpose real estate properties conducive to the production of handcrafted and organically grown cannabis products for medical and recreational adult use in California. The company is based in Anaheim, California, and operates its main facility in Paso Robles.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees

Valuation

Metric
LVVV
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
LVVV

Financial Strength

Metric
LVVV
Quick Ratio
Current Ratio
0.16
Interest Coverage
−23.78
Quick Ratio
LVVV

Profitability

Metric
LVVV
Return on Assets (Normalized)
−236.01%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
LVVV
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRKdgcgrybhLsrfhgd$69.8 Bil
ZTS
Zoetis Inc Class ASwcvlszxmVxy$68.9 Bil
HLN
Haleon PLC ADRHgdblqzQyf$37.7 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRNnvqypjbHjqf$14.8 Bil
VTRS
Viatris IncBrkysydtQhhd$13.6 Bil
RDY
Dr Reddy's Laboratories Ltd ADRCqptvdcpdLqp$11.9 Bil
CTLT
Catalent IncYwjjqyyznRjrrmm$10.1 Bil
PRGO
Perrigo Co PLCDcjxpjvwbFgr$4.2 Bil
CURLF
Curaleaf Holdings IncMzvvltjfTrt$3.6 Bil
PBH
Prestige Consumer Healthcare IncYbmqrxhxWltxy$3.5 Bil

Sponsor Center